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Background: Early diagnosis of pre-cancer lesions would certainly 
contribute to lowering the mortality rate. Lung cancer may develop 
both in the primary bronchus, small bronchioli and alveoli. In peripher-
al part of the lung rarely is known about multistep progression leading 
to adenocarcinoma. The only accepted by WHO lesion in peripheral 
part of the lung is atypical adenomatous hyperplasia (AAH). Ullman et 
all (Virchovs Arch 2003, 442:429-36) proposed a new morphological 
change called Bronchiolar Columnar Cell Dysplasia (BCCD), that may 
be a new preneoplastic lesion preceding invasive adenocarcinoma.
We estimated an occurence of lesions that may lead to an invasive lung 
cancer in archival and current surgical material of the resected lungs 
due to primary cancer. Present study is focused on the question: is 
BCCD a real preneoplastic lesion preceding adenocarcinoma ?
Methods: Four to 6 tissue samples of tumour and 10-15 samples of not 
invaded lung were taken from each specimen of 298 patients surgicaly 
treated for primary non small cell lung cancer (lobectomy, bilobectomy, 
pulmonectomy) in the Department of Thoracic Surgery, Medical Uni-
veristy of Bialystok in 1998-2006. Samples were routinely proceeded 
to the parraﬁn blocks and H+E stained. Slides of each sample were 
investigated for a presence of preneoplastic lesions. In selected samples 
representing BCCD (according to morphological criteria by Ullman et 
al.) immunohistochemical expression of proteins: Ki67, P16, P53 were 
examined. Adequate monoclonal antibodies and protocols proposed by 
DakoCytomation were used.
Results: In 206 of 298 patients (69.1%; 79.6% males, 20.4% females) 
a total of 249 precancerous lesions were observed. In this group, 
predominantingly observed lesion was squamous metaplasia with dys-
plasia of all grades (51.8%) and CIS (4%). AAH was present in 11.6% 
and BCCD in 14.6% of all patients. Cases were divided into groups 
according to histological type of a primary cancer. In a Squamous cell 
lung cancer group (n=102) leading lesion was squamous metaplasia 
(61.4%) without or with all grades of dysplasia. In Adenocarcinoma 
group (n=59) we observed 16.9% of AAH and 23.7% of BCCD. In 
a Large cell lung cancer (n=32) squamous metaplasia was observed 
more often (28.8%) than AAH (8.5%) or BCCD (10.2%). In BCCD 
we observed overexpression of Ki67, P53 and loss of P16 expression. 
The intensity of these changes was related to a grade of bronchiolar 
columnar cell dysplasia. In few cases of BCCD cytoplasmic expression 
of P16 was present.
Conclusions: In the lungs resected due to primary lung cancer BCCD 
occurs predominantly in Adenocarcinoma-group (23.7%). Overexpres-
sion of P53 and loss of P16 with inactivation and transfer of this last to 
cytoplasm may show that BCCD is real preneoplastic lesion leading to 
adenocarcinoma.
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Background: Lung carcinoma is one of the leading causes of cancer 
death in both Asian and Western countries. Histologically, lung carci-
noma is divided into four major subtypes, and one of them, adenocarci-
noma, has a more pronounced tendency to occur in women than other 
histological subtypes (squamous cell carcinoma, small cell carcinoma 
and large cell carcinoma). Animal models of peripheral lung carcino-
genesis have been developed using mouse strains such as A/J, C3H/
He, and CD-1. In this ﬁeld of research, female mice have been used, 
because they show higher tumorigenicity than male mice. We have 
been interested in this characteristic sexual distinction, and therefore 
examined the molecular background of lung adenocarcinogenesis using 
the A/J mouse model and cDNA microarray.
Methods: Both male and female A/J mice were purchased at 5 weeks 
of age and were give a single i.p. dose of 4 mg 4-(methylnitrosamino)-
1-(3-pyridyl)-1-butanone (NNK). In this animal model, tumors develop 
at 10 weeks after carcinogen treatment. Mice were divided into three 
groups. One group was killed just before carcinogen treatment, the 
second was killed at one day after, and the third was killed at 8 weeks 
after. Total RNA was extracted from apparently normal lung tissues of 
each group, and gene expression proﬁles were compared using cDNA 
microarray (CodeLink Mouse Whole Genome Bioarray, GE Health-
Care, USA). For the selected gene (lactoferrin), the localization of its 
mRNA was analyzed by in situ hybridization, and the biological effect 
of its product was examined using several lung adenocarcinoma cell 
lines (A549, PC-14, and Calu-3) and an immortalized atypical adeno-
matous hyperplasia (AAH) cell line (PL16T) (Shimada A. et al. Cancer 
Sci. 96: 668-675, 2005) by relative cell growth and colony-forming 
efﬁciency assay in vitro.
Results: Among 36000 genes, 13 showed a 4-fold or greater differ-
ence in expression level between before and after NNK treatment. A 
further 11 genes showed a 2-fold or greater difference in expression 
level between male and female mice. These differences were conﬁrmed 
by real-time quantitive RT-PCR. Finally, we selected the lactoferrin 
gene, which was expressed at a signiﬁcantly higher level in lung tissue 
of female mice at 8 weeks after carcinogen treatment than in other 
female groups and all male groups. Lactoferrin mRNA was detected 
in the bronchial epithelium of mice by in situ hybridization. Next, the 
biological effect of lactoferrin was examed in vitro using several cell 
lines. Lactoferrin reduced the relative cell growth of Calu-3 and PC-14, 
which express the lactoferrin receptor, but not that of A549, which does 
not express the receptor. The colony-forming efﬁciency of PL16T was 
reduced by lactoferrin treatment.
Conclusion: Using the A/J mouse model of adenocarcinogenesis and 
cDNA microarray, we were able to detect lactoferrin, one of the charac-
teristic genes that may associate the sexual difference in the incidence 
of lung adenocarcinogenesis. Lactoferrin is speciﬁcally and highly 
expressed in carcinogen-treated female A/J mice at a late stage, and is 
biologically associated with cell growth and transformation. The differ-
entially high expression of lactoferrin in female A/J mice may indicate 
the overreaction against the carcinogenic effect.
